XORTX Therapeutics Current Cash

XORTX Therapeutics (XRTX) currently reports a current cash of $250K as of March 2026. That compares with $1.9M in the prior-year period — down 86.8% year over year. Use the charts on this page to explore XORTX Therapeutics's current cash history and peer comparisons.

XORTX Therapeutics's current cash decreased from $1.9M to $250K — a 86.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

XORTX Therapeutics reported $250K in current cash as of March 2026. That compares with $1.9M in the prior-year period — down 86.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $250K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for XORTX Therapeutics, and consider following XRTX for alerts when major investors trade the stock.

XORTX Therapeutics is classified in the Materials sector. On current cash, it currently shows $250K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing XRTX with unrelated industries.